Surgalign could be delisted from Nasdaq

Spinal Tech

Surgalign has 45 days to avoid being delisted from Nasdaq, the company said April 14.

The company on April 10 recieved a notification from Nasdaq's listing qualities department saying the company isn't in compliance with the $10 million minimum stockholders’ equity requirement for listing, according to a news release.

The company has to submit a plan to regain compliance which may include an application to transger its common stock listing to the Nasdaq capital market. Surgalign plans to file documents on or before May 25 to regain compliance.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers